PureTech Health plc (NASDAQ:PRTC – Get Free Report) shares gapped down prior to trading on Thursday . The stock had previously closed at $24.32, but opened at $23.59. PureTech Health shares last traded at $23.59, with a volume of 369 shares.
PureTech Health Price Performance
The business has a 50-day simple moving average of $27.50 and a two-hundred day simple moving average of $26.48.
Institutional Investors Weigh In On PureTech Health
An institutional investor recently bought a new position in PureTech Health stock. AWM Investment Company Inc. acquired a new stake in shares of PureTech Health plc (NASDAQ:PRTC – Free Report) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 6,900 shares of the company’s stock, valued at approximately $197,000. 0.04% of the stock is owned by hedge funds and other institutional investors.
PureTech Health Company Profile
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.
Read More
- Five stocks we like better than PureTech Health
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Sales Breakout Sends This Semiconductor Stock to Record High
- What Are the FAANG Stocks and Are They Good Investments?
- Surprise Buying Opportunity on This Dividend Aristocrat
- What Are the U.K. Market Holidays? How to Invest and Trade
- New Theme Park Powerhouse: Merger Creates Industry-Leading Stock
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.